Most of the somatostatin-like activity from pigeon pancreas was found to correspond to a small species with an apparent molecular weight of 1500-2500. This species was isolated under conditions minimizing intermolecular interactions and protease activities. The isolated product was characterized by two somatostatin radioimmunoassays, a bioassay, endgroup determination, and amino acid analysis. The structure of the isolated compound was determined to be H-Ala-Glycyclo-(Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys)-OH. Additionally, small amounts of des-Ala'-somatostatin, a possible degradation product of pancreatic somatostatin, and a large somatostatin-like species with an apparent molecular weight of 11,000-12,500 were detected. It is concluded that the main somatostatin-like polypeptide isolated from pigeon pancreas is identical to the mammalian hypothalamic tetradecapeptide somatostatin. In 1973, the amino acid sequence of somatostatin (SS) from ovine hypothalamus was reported (1, 2). The sequence for porcine hypothalamic SS was shown to be identical (3). Biologic and immunologic SS-like activities (SSLA) have also been detected in extrahypothalamic parts of the brain (4, 5), pancreas (6, 7), and gastrointestinal tract (7). Although these activities had been observed by bioassay and by immunologic techniques with several antisera directed against different portions of the SS molecule (8), the chemical identities of extrahypothalamic SS-like substances had not been established. In two earlier reports (9, 10) we described the initial purification of SS-like substances from pigeon pancreas, which was chosen as a source of extrahypothalamic SS-like species because of its high content of SSLA (8). We report here details of the isolation and characterization of SS from pigeon pancreas.
METHODS AND MATERIALS Purification. Male pigeons were obtained from Carpenter Squab Ranch (Ventura, CA). For one experiment, 5-20 pigeons were decapitated. The pancreata were removed and submitted to either one of the following procedures:
(A) The pancreata were frozen in liquid nitrogen within 1 min after removal from the animal. The frozen material was then pulverized in liquid nitrogen. The powder was almost totally dissolved in 8 M guanidine hydrochloride/2 M ammonium acetate, pH 2.5, at room temperature and centrifuged for 20 min at 48,000 X g. The supernatant was defatted with an equal volume of diethyl ether/hexane (2:1, vol/vol) and submitted to column chromatography (Bio-Gel P-100, Bio-Rad), which was performed in the presence of 6 M guanidine hydrochloride/i M ammonium acetate, pH 2.5. The chromatographic elution pattern was characterized by the following molecular weight markers: bovine serum gamma globulin, bovine ribonuclease A, cytochrome c (horse heart), lima bean trypsin inhibitor, bovine pancreatic trypsin inhibitor, porcine insulin, porcine '25I-labeled glucagon (New England Nuclear), [125I-Tyrl'SS, bacitracin, and tyrosine. All elution volumes were calculated as partition coefficients KD, referring to the internal volume of the gel. KD = (Ve -Vo4)/(V -V); Ve, elution volume of sample; V0, void volume; VS, elution volume of small solutes (molecular weight <200). Fractions containing SSLA were desalted on Bio-Gel P-2 in the presence of 3 M acetic acid and further purified by DEAE-Sephadex ion-exchange chromatography (A25, Pharmacia) in 0.1 M ammonium acetate, pH 7.0. Final purification was achieved by high-pressure liquid chromatography (HPLC).
The apparatus used for HPLC consisted of Waters Associates models 204 (19) was introduced into the cup as an aqueous solution and dried. The sample (ca. 21 Mg) in 0.48 ml of 3 M acetic acid was then added, mixed with the Polybrene film, and dried. By treatment with aqueous HCI, the 2-anilino-5-thiazolinones of the amino acids were converted into the phenylthiohydantoin (>PhNCS) amino acids, which were identified by gas chromatography (20) and reverse-phase HPLC (21) . The HPLC procedure (21) was modified, the main change being the column resin (a Lichrosorb Rp 8 mixture: 40% 5 ,; 60% 10 A, Merck, Darmstadt). All >PhNCS amino acids could be resolved and quantitated except Met>PhNCS and Val>PhNCS. The detection limit was found to be about 60 pmol. Usually, 1-2 nmol of >PhNCS amino acid was applied. Details about packing of the columns, elution program, and resolution will be described elsewhere (J. A. Rodkey and C. D. Bennett).
Radioimmunoassays. SSLA was determined by radioimmunoassays employing the centrally directed SS antibody S201 (22) or the NH2-terminally directed SS antibody S39 (8) .
['25I-Tyrl]SS and [125I-Tyrll]SS were prepared as described (8) .
SS Bioassay. The biologic activity of purified pancreatic fractions was tested by their ability to inhibit growth hormone secretion by primary rat anterior pituitary cell cultures used 4 days after plating (23) .
RESULTS
Each of the isolation procedures was successfully applied to the isolation of SS from pigeon pancreas. In procedure A, three to five pancreata were homogenized in liquid nitrogen and extracted by 8 M guanidine hydrochloride at pH 2.5. About [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Mug of SS equivalents as determined in the SS radioimmunoassay Pancreatic SS was further purified by ion-exchange chromatography (DEAE-Sephadex) and reverse-phase HPLC. The purification was monitored by SS radioimmunoassay (antiserum S201) and protein determination. A 7500-fold purification and a specific activity of 0.97 ,ug of SS per ,ug of protein were finally achieved ( Table 1 ). The overall yield was determined to be 15-20% (Table 1) . Because guanidine hydrochloride is not lyophilizable, the volume of the initial extract limited this procedure to only a few pancreata per extraction.
For the preparation of larger amounts of pancreatic SS, another purification procedure was developed (procedure B). In this procedure, SSLA was extracted from 10-20 pigeons by hot 2 M acetic acid, purified by acetone precipitation, defatted, and then submitted to reverse-phase HPLC. Procedure B gave the same overall yield as procedure A (Table 2 ) and required only 2 days for isolation. An aliquot of the acetic acid extract after acetone treatment and defatting was filtered through Bio-Gel P-100 in the presence of 6 M guanidine hydrochloride. More than 99% of the gel-filtered SSLA appeared as small species (Fig. 1) .
Additionally, a large SS-like species was found which represented 0.3 to 0.5% of the gel filtered SLA and eluted with KD of 0.22 in the experiment presented here (Fig. 1) For further characterization, pancreatic and synthetic hypothalamic SS were reduced under alkaline conditions and carboxymethylated with iodoacetate at pH 8.7 or 6.0. The reaction could easily be followed by reverse-phase HPLC, because hypothalamic and pancreatic SS and their reduction and carboxymethylation products were resolved on ,-Bondapak C18 columns, eluted by TEAP or TEAF buffers.
At pH 8.7, hypothalamic and pancreatic SS were almost quantitatively (>95%) carboxymethylated to products that were eluted from ,i-Bondapak C18 columns with the same retention time but earlier than tetradecapeptide SS (Fig. 2B) .
When carboxymethylated pancreatic SS was hydrolyzed by the methanesulfonic acid method and analyzed for amino acids, 2.0 mol of Cm-cysteine per mol of alanine was found (Table  3) . No cystine or cysteine was detectable. The other amino acid concentrations deviated after normalization to alanine by maximally 10% from the amino acid composition of hypothalamic SS (Table 3) . Similar results were found for the carboxymethylation product of synthetic hypothalamic SS. These results suggest that both cysteine residues of pancreatic SS were carboxymethylated at pH 8.7 and that no other amino acid was affected.
Carboxymethylation at pH 6.0 resulted in products that again were eluted with the same retention time but later than tetradecapeptide SS in reverse-phase HPLC under the conditions described above. The yield was 60-70%. These carboxymethylation products contained 1 mol of Cm-cysteine per mol of alanine, according to amino acid analysis, performed after hydrolysis with the methanesulfonic acid method (13) . Probably only one cysteine residue of hypothalamic or pancreatic SS had reacted under these carboxymethylation conditions.
Endgroup determination of purified pancreatic SS was performed with the dansyl technique. As for hypothalamic SS, alanine was found as the only NH2 terminus.
When the immunoreactivity of pancreatic SS was determined in radioimmunoassays using the NH2-terminally directed SS antibody S39 or the centrally directed SS antibody S201, an S201-to-S39 activity ratio of 0.98 + 0.12 (SD) was found. In contrast to hypothalamic and pancreatic SS, few SS analogs have shown the same immunologic activity versus both antibodies (22) .
Purified pancreatic SS inhibited growth hormone secretion from cultured rat anterior pituitary cells (Fig. 3) . The (Table 4) . On the basis of the sequence analysis (Table 4) , pancreatic SS was a polypeptide with the same primary structure as hypothalamic SS: H-Ala-Gly-Cys-Lys-Asn-Phe-PheTrp-Lys-Thr-Phe-Thr-Ser-Cys-OH.
Whether pancreatic SS contained a disulfide bridge, like hypothalamic SS (2), could not be determined from the sequence analysis data alone (Table 4) . But because isolated pancreatic SS behaved like synthetic hypothalamic cyclic SS in HPLC ( Fig. 2A) under conditions that resolve linear and cyclic SS, it was concluded that primary and secondary structure of the isolated pancreatic and hypothalamic somatostatin were the same, suggesting the structure H-Ala-Gly-cyclo-(Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys)-OH for the isolated polypeptide. The sequence analysis data showed, besides the structure of tetradecapeptide SS, the structure of des-Alal-SS as a contaminant representing about 4% of SS. Our main concern during the purification of pancreatic SS-like species was the high proteolytic activity of pancreas, which could cause partial digestion of the peptides to be isolated. We have approached this problem by using specific and nonspecific methods of protease inhibition. Soya bean trypsin inhibitor, bacitracin, and pepstatin A were used as specific inhibitors. Especially, application of guanidine hydrochloride was considered to be an efficient nonspecific method to inactivate proteases (25) . From the observation that the same SS-like species was isolated by two different purification procedures, it is suggested that the isolated compound is not a digestion product formed during purification.
The biologic significance of the observation that one of the isolated fractions of pancreatic SS contained a small quantity of des-Alal-SS is not clearly understood. Whether this tridecapeptide occurs naturally or is only generated during extraction and isolation has not been determined. Because SS analogs with modifications (including deletions) of the first two amino acids have high potency (26) , des-Alal-SS may be of physiologic significance.
Characterization of pancreatic SS has revealed that hypothalamic and pancreatic SS do not differ in biologic potency, immunologic activity in two different radioimmunoassays, NH2 terminus, amino acid composition, HPLC before and after two chemical modifications, and primary and secondary structure.
